These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 22607939)

  • 21. DNA methylated alleles of the phenylalanine hydroxylase promoter remodeled at elevated phenylalanine levels in newborns with hyperphenylalaninemia.
    Item CB; Farhadi S; Schanzer A; Greber-Platzer S
    Clin Biochem; 2017 Aug; 50(12):729-732. PubMed ID: 28389235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of blood phenylalanine concentration on Kuvan™ response in phenylketonuria.
    Elsas LJ; Greto J; Wierenga A
    Mol Genet Metab; 2011 Apr; 102(4):407-12. PubMed ID: 21216643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular genetics and impact of residual in vitro phenylalanine hydroxylase activity on tetrahydrobiopterin responsiveness in Turkish PKU population.
    Dobrowolski SF; Heintz C; Miller T; Ellingson C; Ellingson C; Ozer I; Gökçay G; Baykal T; Thöny B; Demirkol M; Blau N
    Mol Genet Metab; 2011 Feb; 102(2):116-21. PubMed ID: 21147011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tetrahydrobiopterin loading test in differential diagnosis among hyperphenylalaninemia patients].
    Zhang ZX; Ye J; Qiu WJ; Han LS; Gu XF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):438-40. PubMed ID: 16086286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tetrahydrobiopterin (BH4) responsiveness in neonates with hyperphenylalaninemia: a semi-mechanistically-based, nonlinear mixed-effect modeling.
    Trefz F; Lichtenberger O; Blau N; Muntau AC; Feillet F; Bélanger-Quintana A; van Spronsen F; Munafo A
    Mol Genet Metab; 2015 Apr; 114(4):564-9. PubMed ID: 25726095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tetrahydrobiopterin responsiveness of patients with phenylalanine hydroxylase deficiency.
    Giugliani L; Sitta A; Vargas CR; Santana-da-Silva LC; Nalin T; Saraiva-Pereira ML; Giugliani R; Schwartz IV
    J Pediatr (Rio J); 2011 May-Jun 8; 87(3):245-51. PubMed ID: 21660367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Screening and diagnosis of tetrahydrobiopterin responsive phenylalanine hydroxylase deficiency with tetrahydrobiopterin loading test].
    Zhang ZX; Ye J; Qiu WJ; Han LS; Gu XF
    Zhonghua Er Ke Za Zhi; 2005 May; 43(5):335-9. PubMed ID: 15924746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A structural hypothesis for BH4 responsiveness in patients with mild forms of hyperphenylalaninaemia and phenylketonuria.
    Erlandsen H; Stevens RC
    J Inherit Metab Dis; 2001 Apr; 24(2):213-30. PubMed ID: 11405341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of tetrahydrobiopterin (BH4) responsiveness in phenylketonuria.
    Fiege B; Blau N
    J Pediatr; 2007 Jun; 150(6):627-30. PubMed ID: 17517248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term treatment of patients with mild and classical phenylketonuria by tetrahydrobiopterin.
    Trefz FK; Scheible D; Frauendienst-Egger G; Korall H; Blau N
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S75-80. PubMed ID: 16242984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic Control of Patients with Phenylketonuria in a Portuguese Metabolic Centre Comparing Three Different Recommendations.
    Kanufre V; Almeida MF; Barbosa CS; Carmona C; Bandeira A; Martins E; Rocha S; Guimas A; Ribeiro R; MacDonald A; Pinto A; Rocha JC
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34578995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early Screening for Tetrahydrobiopterin Responsiveness in Phenylketonuria.
    Porta F; Spada M; Ponzone A
    Pediatrics; 2017 Aug; 140(2):. PubMed ID: 28679641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenylalanine hydroxylase deficiency: molecular epidemiology and predictable BH4-responsiveness in South Portugal PKU patients.
    Rivera I; Mendes D; Afonso Â; Barroso M; Ramos R; Janeiro P; Oliveira A; Gaspar A; Tavares de Almeida I
    Mol Genet Metab; 2011; 104 Suppl():S86-92. PubMed ID: 21871829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spanish BH4-responsive phenylalanine hydroxylase-deficient patients: evolution of seven patients on long-term treatment with tetrahydrobiopterin.
    Bélanger-Quintana A; García MJ; Castro M; Desviat LR; Pérez B; Mejía B; Ugarte M; Martínez-Pardo M
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S61-6. PubMed ID: 16165389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency, state of the art.
    Spaapen LJ; Rubio-Gozalbo ME
    Mol Genet Metab; 2003 Feb; 78(2):93-9. PubMed ID: 12618080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetrahydrobiopterin responsiveness: results of the BH4 loading test in 31 Spanish PKU patients and correlation with their genotype.
    Desviat LR; Pérez B; Bèlanger-Quintana A; Castro M; Aguado C; Sánchez A; García MJ; Martínez-Pardo M; Ugarte M
    Mol Genet Metab; 2004; 83(1-2):157-62. PubMed ID: 15464430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy, safety and population pharmacokinetics of sapropterin in PKU patients <4 years: results from the SPARK open-label, multicentre, randomized phase IIIb trial.
    Muntau AC; Burlina A; Eyskens F; Freisinger P; De Laet C; Leuzzi V; Rutsch F; Sivri HS; Vijay S; Bal MO; Gramer G; Pazdírková R; Cleary M; Lotz-Havla AS; Munafo A; Mould DR; Moreau-Stucker F; Rogoff D
    Orphanet J Rare Dis; 2017 Mar; 12(1):47. PubMed ID: 28274234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluctuations in phenylalanine concentrations in phenylketonuria: a review of possible relationships with outcomes.
    Cleary M; Trefz F; Muntau AC; Feillet F; van Spronsen FJ; Burlina A; Bélanger-Quintana A; Giżewska M; Gasteyger C; Bettiol E; Blau N; MacDonald A
    Mol Genet Metab; 2013 Dec; 110(4):418-23. PubMed ID: 24090706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved metabolic control in tetrahydrobiopterin (BH4), responsive phenylketonuria with sapropterin administered in two divided doses vs. a single daily dose.
    Kör D; Yılmaz BŞ; Bulut FD; Ceylaner S; Mungan NÖ
    J Pediatr Endocrinol Metab; 2017 Jul; 30(7):713-718. PubMed ID: 28593914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.